To view the CME, MedScape requires visitors to create a free account.
1. A patient with diabetes, obesity, and lower urinary tract symptoms (LUTS)
Patient simulation cases
The goal of this activity is to provide guidance to clinicians who treat male patients with LUTS symptoms and comorbidities regarding appropriate clinical workup, diagnosis, and treatment options, based on clinical data and guidelines, expert opinion, and patient preference to optimize individualized patient care.
Experts
Alex W. Pastuszak, MD, PhD
Assistant Professor, Division of Urology
Department of Urology,
Department of Surgery,
University of Utah,
Salt Lake City, Utah, United States
Department of Urology,
Department of Surgery,
University of Utah,
Salt Lake City, Utah, United States
Hugh Jones, BSc, MD, FRCP
Professor, Barnsley Hospital NHS Foundation Trust,
University of Sheffield, Barnsley, South Yorkshire, United Kingdom
University of Sheffield, Barnsley, South Yorkshire, United Kingdom
Learning objectives
Upon completion of this activity, participants will:
- Have greater competence related to
- Diagnosing a patient with comorbid medical disorders, who also has lower urinary tract symptoms (LUTS)
- The development of individualized treatment plans based on guidelines, expert guidance, and patient preference
Target audience
This educational activity is intended for an international audience of urologists, primary care physicians, diabetologists and endocrinologists who practice outside of the US.
2. Hypogonadism and cardiovascular and metabolic health: should we consider testosterone replacement?
Test-and-teach
This activity is intended to improve physicians’ knowledge regarding the recent clinical data on the benefits of testosterone replacement in hypogonadic men with various comorbid conditions, best practice for the accurate detection and diagnosis of male hypogonadism, and optimal treatment strategies for men with hypogonadism.
Experts
Geoffrey Hackett, MD, FRCPI, MRCGP
Professor of Sexual Medicine, Aston University Birmingham;
Consultant in Urology and Sexual Medicine, University Hospitals Birmingham;
Birmingham, United Kingdom
Consultant in Urology and Sexual Medicine, University Hospitals Birmingham;
Birmingham, United Kingdom
Learning objectives
Upon completion of this activity, participants will be able to:
- Have increased knowledge of:
- Hypogonadism in men and its impact on overall health and wellbeing.
- Recent clinical data on the benefits of testosterone replacement in hypogonadic men with various comorbid conditions.
- Demonstrate greater competence in their ability to:
- Accurately detect and diagnose male hypogonadism.
- Employ best practice in the safe and effective treatment of men with hypogonadism.
Target audience
This educational activity is intended for an international audience of non-US healthcare professionals, specifically diabetologists and endocrinologists, urologists, and primary care physicians involved in the management of patients with, or at risk for, hypogonadism.
3. New perspectives on hypogonadism and testosterone replacement in clinical practice
Expert column
The goals of this activity are to help participants identify patients with hypogonadism; provide an overview of the impact of the condition on quality of life and mortality; and review the role of testosterone therapy in prostate, metabolic, and cardiovascular health.
Experts
Alvaro Morales, MD, FRCSC, FACS
Professor Emeritus,
Department of Urology,
School of Medicine, Queen's University,
Kingston, Ontario, Canada
Department of Urology,
School of Medicine, Queen's University,
Kingston, Ontario, Canada
Abraham Morgentaler, MD, FACS
Founder and Director, Men's Health Boston;
Associate Clinical Professor of Surgery (Urology), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States
Associate Clinical Professor of Surgery (Urology), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States
Geoffrey Hackett, MD, FRCPI, MRCGP
Professor of Sexual Medicine, Aston University Birmingham;
Consultant in Urology and Sexual Medicine, University Hospitals Birmingham, United Kingdom
Consultant in Urology and Sexual Medicine, University Hospitals Birmingham, United Kingdom
Michael Zitzmann, MD, PhD
Professor of Medicine, Endocrinologist, Andrologist, Diabetologist; Sexual Medicine (FECSM); Clinical Andrology Centre for Reproductive Medicine and Andrology, Münster, Germany
Learning objectives
Upon completion of this activity, participants will be able to:
- Identify the clinical impact of testosterone deficiency on men’s health, quality of life, and mortality
- Examine the latest clinical data on the interrelationships between hypogonadism and metabolic and cardiovascular risk factors, and between hypogonadism and prostate health
- Explain how to identify men at risk, diagnose hypogonadism, and how to treat and monitor patients, taking into account the latest clinical data and guidelines
Target audience
This educational activity is intended for an international audience of non-US healthcare professionals, specifically diabetologists and endocrinologists, urologists, and primary care physicians involved in the management of patients with, or at risk for, hypogonadism.
Recommendations
Copyright © 2021, Bayer AG
PP-NEB-ALL-0222-1 April 2021
